119TiP An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG)

Autor:	C. Gessner, F. Griesinger, R. Shah, T. Talbot, S. Venkateshan, A.K. Vadanahalli Shankar, A. Seluzhytsky, D.M. Marsden
Rok vydání:	2022
Předmět:	Oncology Immunology and Allergy
Zdroj:	Immuno-Oncology and Technology. 16:100223
ISSN:	2590-0188
DOI:	10.1016/j.iotech.2022.100223
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::950c9071ab83ce4bb65fa659c9f3bef5 https://doi.org/10.1016/j.iotech.2022.100223 Zobrazit plný text záznamu